Dapirolizumab pegol is an investigational Fc-free polyethylene glycol-conjugated antigen-binding fragment that inhibits CD40 ligand signaling.

UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...

UCB and Biogen’s drug dapirolizumab pegol has met the primary endpoint of improvement in disease activity in lupus patients.

Tonix's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting ...

Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, will participate in a fireside chat at the upcoming Cantor Global ...

Thomas brings more than 20 years of commercial and operations experience in the biopharmaceutical industry to Tonix Tonix is ...

异常散点图：患儿入院当天进行血常规检查，检验人员在审核血常规报告时发现血常规三系均减低，同时注意到白细胞散点图异常，表现为在中性粒区域左下方和淋巴区域正下方有异常细胞团（红色圈内），疑似异常细胞和有核红细胞… ...

It is administered through intratumoral route as a suspension and it is an oncolytic adenovirus consist of serotype 5 from serotype 35 (Ad5/35) which is modified to express CD40 ligand (CD40L) and ...

CD40 配体 (CD40L) 抗体市场调研报告呈现了全球与中国CD40 配体 (CD40L) 抗体市场规模发展趋势。2023年全球CD40 配体 (CD40L) 抗体市场规模达到71.65亿元（人民币），中国CD40 配体 (CD40L) 抗体市场规模达x.x亿元，同时报告中也给出了2023年中国CD40 配体 (CD40L) 抗体进口和 ...

Similarly, the universities portfolio in Preclinical comprises 2 molecule. CD40 ligand or CD40L is a protein that is primarily expressed on activated T cells and is a member of the TNF superfamily.

Background: Currently, evidence regarding the causal relationship between primary immunodeficiency-related genes and varicella-zoster virus reactivation syndrome is limited and inconsistent. Therefore ...